CRNX
NASDAQ · Pharmaceuticals
Crinetics Pharmaceuticals In
$84.95
+0.11 (+0.13%)
Performance
1D
—
1W
—
1M
—
3M
+0.00%
6M
+132.42%
1Y
+112.38%
YTD
+81.79%
Open$84.96
Previous Close$84.84
Day High$85.01
Day Low$84.92
52W High$85.01
52W Low$32.30
Volume—
Avg Volume3.02M
Market Cap9.01B
P/E Ratio—
EPS$-5.05
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$38.66
Above
SMA 200
$41.79
Above
RSI (14)
87.1
Overbought
Trend
Death Cross
Bearish
Analyst Ratings
Hold
20 analysts
Price Target
-41.8% upside
Current
$84.95
$84.95
Target
$49.40
$49.40
$38.77
$49.40 avg
$74.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.68M | 7.38M | 1.14B |
| Net Income | -524,874,217 | -401,928,695 | 346.78M |
| Profit Margin | -6,046.2% | -5,743.9% | 30.3% |
| EBITDA | -578,526,564 | -467,625,487 | 475.78M |
| Free Cash Flow | — | — | 205.84M |
| Rev Growth | +17.5% | +17.5% | +24.5% |
| Debt/Equity | — | — | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |